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Abstract  
The subject of the work was the experimental verification of the negative influence of gravity sets in a pressure volumetric 
infusion pump with an impact on the accuracy of infusion solution dosing. The quality criterion for gravity sets was the 
accuracy of the flow versus the reference set by the volumetric infusion pump. The solution consisted of 14-hour 
measurements with two types of gravity sets, Intrafix® Primeline sets were used as universal sets and Standardline IS 
103 gravity sets. The insulin pump flow rate was set at 300 ml/h and 50 ml/h, and the actual flow rate of the infusion 
solution was recorded every hour using a graduated cylinder. Used gravity sets were also processed by mechanical tests, 
unused sets were subjected to these tests and the obtained data were compared with each other. Experiments carried out 
showed that at the set flow rate of 300 ml/h, the flow error with the universal set was -3% and at a set flow rate of 50 ml/h 
the error was +2.3%. Flow accuracy using gravity sets was worse, a flow error of -7.2% was detected for a flow rate of 
50 ml/h and a flow error of -7.7% was measured for 300 ml/h. The volumetric pump used declares a tolerated inaccuracy 
of ± 3% when used with standard infusion sets. Based on the data, it can be concluded that the replacement of set types 
has an influence on the dosage of infusion solutions. 
Keywords  
volumetric infusion pump, set for gravity-fed infusions, infusion therapy risks, flow accuracy, infusion set prolongation 
 
Introduction 
In healthcare, infusion therapy is the most common 
way of administering substances to the patient. The 
correct functionality of infusion therapy is based not 
only on the gravitational or pressure principle of the 
method, but also on the type of administration sets used 
[1–3]. The mutual compatibility of the infusion pump 
and the sets ensures a functional assembly that can meet 
the required requirements, especially in terms of flow 
accuracy. A breach of the compatibility condition be-
tween the device and the infusion set may be more likely 
than is expected. Subsequent risks associated with 
potential confusion may also concern the safety of the 
treatment and the health of the patient, which is essential 
in healthcare [2, 4, 5]. 
Two types of infusion sets were the subject of experi-
mental testing, the universal Intrafix® Primeline type 
from B | Braun (Germany). The reason for this step is 
that it is currently the most used set type, in some  
 
medical facilities it has even completely replaced 
conventional gravity sets. The other testing sets are 
Czech products manufactured by Gama® known as IS-
103. According to publicly available offers of compa-
nies dealing in medical supplies, these are the most 
accessible (and probably the most commonly used) 
exclusively gravity sets in the Czech Republic. The 
Forlong 600II volumetric pump from the Chinese manu-
facturer Forlong Medical Instruments Ltd. will be used 
for measurements with a linear vane peristaltic pump. 
The key point of the work is, based on the results of 
practical testing, to evaluate the effect of using a gravity 
infusion set in a volumetric pump application on dosing 
accuracy and risks in the safety of the treatment. Its 
solution will consist first of the theoretical determination 
of negative effects and possible consequences of con-
fusion of different types of sets. The next step will then 
be to perform experimental measurements and analyse 
the data to verify the assumed inaccuracies of dosing. 
Finally, the data obtained will be evaluated concerning 
the theoretical opinions. 
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Pressure  In fusion Therapy  
In addition to gravity infusion therapy, the method of 
pressure infusion therapy is one of the most common 
[1]. The methods belonging to this group of infusions 
have an electrical force-generating device, the action of 
which generates the required pressure in the infusion 
set [6]. 
Pressure therapies include linear dispensers and infu-
sion pumps. Treatment using an infusion pump is an en-
hancement of the gravity method and was developed to 
provide more accurate dosing and stabilization over time 
[6]. It consists of creating pressure in the tube by cy-
clically compressing it with rollers using the peristaltic 
movement [7, 8]. 
In the infusion technique, lamella type pumps are 
most often used. In their case, the peristaltic movement 
of the set is not created by the cyclical rotation of the 
rollers, but by the movement of the slats. These are 
arranged in a linear and controlled movement of the 
rotary shaft [9, 10]. 
Infusion pumps must meet the requirements of IEC 
60601-2-24 [11]. The time of the infusion set replace-
ment interval was not specified in the manual for the use 
of the infusion pump or in the instructions for use for 
the given infusion sets. For this reason, the standard 
EN 60601-2-24: 2015 was studied, specifically article 
201.12.1.102 Accuracy tests of this standard. However, 
other standards are applied to them, such as EN ISO 
8536-8, which imposes requirements such as air perme-
ability, microorganisms, and liquids out, or allowing 
fluid to be injected into a tube [12]. Also, the standard 
EN ISO 8536-4 is applicable to infusion pumps speci-
fying that the infusion set should not deliver liquid at 
a rate greater than 100 ml/min [13]. 
Infus ion Sets and Standard Requirem ents  
Pressure devices for infusion therapy require special 
demands on the properties and structure of the sets used, 
thereby specializing in infusion sets for pressure therapy 
[1, 14]. Obviously, infusion pumps require different set 
properties than those required for gravity therapy [15]. 
Since infusion pressure sets may be confused with 
gravity sets, the question is whether dosing accuracy is 
maintained in this case, or the gravity set is destroyed by 
a volumetric infusion pump [16, 17]. 
The requirements of the legislation relate mainly to 
the material from which the files are made. Also 
important are the physical properties of the material 
concerning the flow, tightness and strength require-
ments of the infusion sets. Infusion sets, as well as 
devices for infusion technology, fall within the regulated 
area of medical devices, governed by the European 
MDD 93/42/EEC [18]. According to the Directive, 
infusion sets are classified in Class IIa, subject to Rule 
6—All surgically-invasive devices for transient use fall 
into Class IIa. To meet all MDD 93/42/EEC require-
ments, the manufacturer is required to demonstrate the 
overall safety and functionality of the infusion set [18]. 
This is done by performing mechanical tests as defined 
in EN ISO 8536-4 [13]. This standard defines the re-
quirements for mechanical tests, the functionality of the 
kit and the requirements for the material from which the 
kit is made. The testing of materials for biocompatibility 
is performed according to ISO 10993-1, where require-
ments are set for the performance of the tests, including 
cytotoxicity and irritability, as well as the evaluation 
of the results of the tests performed [19]. Due to the 
nature of the medical device, a risk analysis according 
to EN ISO 14971 should be carried out and all risks 
arising from the use of the medical device should be 
minimized [20]. 
Determination of mechanical  
effects affecting the properties of 
infusion sets and dosing accuracy  
Several factors contribute to changes in set properties. 
The fluctuation of the gravity infusion dosage is mainly 
due to the physical characteristics of the infusion set. 
With regard to material changes of the infusion set, the 
most significant influence is the pressure of the peri-
staltic cylinders, slats and the safety control wheel on the 
tubing of the set. This applied pressure results in some 
adaptation of the tubing, which may result in a parasitic 
flow despite the initially fully enclosed push. At this 
point, it depends on the characteristics of the infusion 
sets used, assets intended for other uses will not meet the 
required mechanical properties [6, 10]. It has been 
shown that if polymeric substances are exposed to 
external pressure for a certain period, they can change 
their internal structure. This phenomenon may result in 
the loss of original material properties such as elasticity. 
Thus, the compression may deform the tubing of the 
set so that its inner diameter is reduced, which may 
affect subsequent flow. Another very important factor 
involved in the behaviour of the polymer tube during 
linear vane pump operation is the duration of the 
infusion treatment itself. However, the standard on in-
fusion sets and conduits does not set any maximum 
length of use per kit [1, 10, 21]. 
Impact  o f  In fus ion Set  Type Replacement  
Also, during the course of the infusion treatment, the 
different types of sets, designed for different methods of 
application, differ from each other in their properties. 
Individual types must be properly and visibly marked 
according to standards. However, personnel may be 
mistaken, and the wrong infusion set may be selected for 
the method [1, 8]. Due to the possible occurrence of 
errors in the accuracy of treatment, a more serious case 
is the use of a gravity infusion line for drug delivery with 
a volumetric infusion pump. One of the risks is, for 
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example, the parasitic free flow under the pump fins 
during their peristaltic movement. Gravity infusion sets 
are made of harder materials than infusion sets suitable 
for pressure equipment, which partially reduces their 
flexibility [6, 8]. Another cause may be a situation 
where the long-term compression of the blades of the 
pump leads to a flattening of the cross-section of the 
tubing, which in the peristaltic movement of the blades 
may not contain the volume calculated by the pump. The 
resulting flow rate may be lower than the set value [8, 9]. 
Flow measurement 
Since the aforementioned phenomena and effects on 
the course and accuracy of infusion therapy are only 
assumed and theoretically determined, it is necessary to 
support them with real, experimentally obtained data. 
Measuring Chain  
The measurement chain was composed of an original 
2,000 ml saline (0.9% aqueous NaCl) infusion bag 
from Baxter (United States), a Forlong 600II volumetric 
infusion pump from Forlong Medical Instruments Ltd. 
with a linear vane peristaltic pump and standard infusion 
sets of several types, available on the Czech market and 
thus properly approved for use in infusion therapy. 
A device with valid safety controls has been used and is 
therefore suitable for use in medical operations and with 
two types of infusion sets, whose properties are listed in 
the next chapter. The parameters specified in the Instruc-
tions for Use indicate a tolerated inaccuracy of ±3% 
when used with standard infusion sets. The measure-
ment was performed under standard conditions (tem-
perature 21 °C, pressure 980 hPa, humidity 45%). 
Infus ion Sets in  F low Measur ement  
Two types of infusion sets, B | Braun's Intrafix® 
Primeline and IS-103 sets by Gama®, were the subject 
of the experimental testing. The features of Intrafix® 
Primeline Universal Sets include a maximum pressure 
of 2 kPa, a length of 150 cm and an inner diameter of 
3 mm. It is made of DEHP free PVC. Standardline 
IS-103 gravity sets have a length of 140 cm, an inner 
diameter of 3 mm, and the maximum pressure is not 
shown. PVC is used for production. 
Cal ibrat ion of  the in fus ion pump  
Calibration was performed for the recommended 
infusion set according to the instructions provided in the 
user manual for the Forlong 600II infusion pump. In 
addition, verification of the infusion pump and the new 
infusion set was performed using the drop method using 
a measuring cylinder with an accuracy of 0.5 ml for 60 
minutes. 
It should be emphasized that despite the calibration of 
the pump for a given type of set, the time aspect has 
a great influence on the mechanical degradation of that 
set and thus the accuracy of dosing. The aim was to 
determine the behaviour of infusion set materials when 
the recommended time is exceeded, as in practice it 
often happens that the infusion therapy is applied during 
the night and sleep for a longer period of time. 
Measurement Param eters  
A set of experimental measurements was performed 
to obtain data on development and changes in flow accu-
racy during the infusion application process. Measured 
samples were taken every hour with a graduated cylin-
der, which allows measurements with an accuracy of 
±0.5 ml. The total length of one measurement cycle with 
one infusion set was 14 hours. The technical specifi-
cation of the Forlong pump makes it possible to set 
the flow rate of the dosing substance within the range of 
1–2,000 ml/h with an accuracy of 0.1 ml. Flow rates 
of 50 ml/h and 300 ml/h were used. Two flow rates 
allow verification of the effect of slow slat movements 
on changes in the infusion set properties different from 
the faster operation of the pump. 
The numbers of measurements with individual types 
of infusion sets were determined according to the 
number of pieces obtained. Five measurements with 
Intrafix® Primeline infusion sets and two measurements 
with Gama® IS-103 sets were performed for each of the 
units tested. 
Evaluat ion of  Measured  Data  
The desired and predicted flow values set on the pump 
are the reference levels of the measurement to which the 
resulting measured and acquired values flow. Absolute 
differences and relative differences are calculated from 
the measured flow values. 
The formulas used are as follows: 
Absolute Difference 
Δ𝑉𝑛=𝑉𝑛−𝑉𝑟 (1) 
Relative Differences 
𝛿𝑉𝑛=((𝑉𝑛/𝑉𝑟) −1) ·100 (2) 
Where: 
𝑉𝑛 is the value of the flow being measured; 
𝑉𝑟 the reference value of 50 or 300 ml/h. 
Intraf ix®  Pr imel ine In fusion Sets 
Measurement  
Table 1 shows the measured flow values for a pump 
setting of 300 ml/h and 50 ml/h. The measured values 
are also given with an estimate of the measurement error 
±0.5 ml, which is given by the resolution of the mea-
suring cylinder. Table 2 shows the absolute and relative 
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difference values of the flow of the individual samples 
of Intrafix® Primeline infusion sets for 300 ml/h. In 
Table 3, the absolute and relative difference values of 
the flow of the individual samples of Intrafix® Prime-
line infusion sets for 50 ml/h are presented. Values are 
given in a range that includes a possible measurement 
error. These values should be indicators of flow accu-
racy. Figure 1 and Figure 2 plot the measured flow 
values. 
From the values given in Table 1, the decreasing trend 
of the measured flow as a function of the measurement 
time can be seen. 
Table 1: The measured flow values for 300 ml/h and 
50 ml/h for Set 1–4. 
 
Fig. 1: The measured flow values compared to reference 
300 ml/h. 
 
Fig. 2: The measured flow values compared to reference 
50 ml/h. 
Table 2: Absolute and relative difference values of flow 
for Set 1 and Set 2–300 ml/h. 
Time 
(h) 
Set 1 Set 2 
Absolute 
diff. (ml) 
Relative 
diff. (%) 
Absolute 
diff. (ml) 
Relative 
diff. (%) 
1 -0.5–0.5 0 -2.5– (-3.5) -1 
2 -5.5– (-6.5) -2 -2.5– (-3.5) -1 
3 -2.5– (-3.5) -1 -5.5– (-6.5) -2 
4 -2.5– (-3.5) -1 -5.5– (-6.5) -2 
5 -5.5– (-6.5) -2 -8.5– (-9.5) -3 
6 -5.5– (-6.5) -2 -8.5– (-9.5) -3 
7 -8.5– (-9.5) -3 -5.5– (-6.5) -2 
8 -8.5– (-9.5) -3 -2.5– (-3.5) -1 
9 -5.5– (-6,5) -2 -5.5– (-6.5) -2 
10 -8.5– (-9.5) -3 -5.5– (-6.5) -2 
11 -11.5– (-12.5) -4 -8.5– (-9.5) -3 
12 -14.5– (-15.5) -5 -14.5– (-15.5) -5 
13 -11.5– (-12.5) -4 -8.5– (-9.5) -3 
14 -11.5– (-12.5) -4 -8.5– (-9.5) -3 
Aver. -7.714 -2.57 -7.07 -2.36 
The values of the absolute difference and relative 
difference of flow confirm the decreasing flow trend. 
According to the relative difference, it can be 
determined that the inaccuracy of the average flow rate 
does not exceed the declared ± 3% for both 
measurement variants. The flow quality is not 
insignificant when using the tested sets, the dosing 
accuracy has a decreasing tendency in all measured 
settings. But based on the measured flow rate, the dosing 
accuracy in terms of therapy quality is fine.  
Time 
(h) 
Set 1 
- 
300 ml/h 
Set 2 
- 
300 ml/h 
Set 3 
- 
50 ml/h 
Set 4 
- 
50 ml/h 
Flow 
(ml/h) 
Flow 
(ml/h) 
Flow 
(ml/h) 
Flow 
(ml/h) 
1 300 ± 0.5 297 ± 0.5 51 ± 0.5 52.5 ± 0.5 
2 294 ± 0.5 297 ± 0.5 51.5 ± 0.5 52 ± 0.5 
3 297 ± 0.5 294 ± 0.5 51 ± 0.5 52.5 ± 0.5 
4 297 ± 0.5 294 ± 0.5 50.5 ± 0.5 52 ± 0.5 
5 294 ± 0.5 291 ± 0.5 50.5 ± 0.5 52.5 ± 0.5 
6 294 ± 0.5 291 ± 0.5 50 ± 0.5 51.5 ± 0.5 
7 291 ± 0.5 294 ± 0.5 50 ± 0.5 51.5 ± 0.5 
8 291 ± 0.5 297 ± 0.5 50 ± 0.5 51 ± 0.5 
9 294 ± 0.5 294 ± 0.5 49.5 ± 0.5 50.5 ± 0.5 
10 291 ± 0.5 294 ± 0.5 49 ± 0.5 50.5 ± 0.5 
11 288 ± 0.5 291 ± 0.5 49.5 ± 0.5 50.5 ± 0.5 
12 285 ± 0.5 285 ± 0.5 49 ± 0.5 50 ± 0.5 
13 288 ± 0.5 291 ± 0.5 49 ± 0.5 49.5 ± 0.5 
14 288 ± 0.5 291 ± 0.5 48.5 ± 0.5 49.5 ± 0.5 
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Table 3: Absolute and relative difference values of flow 
for Set 3 and Set 4–50 ml/h. 
Time 
(h) 
Set 3 Set 4 
Absolute 
diff. (ml) 
Relative 
diff. (%) 
Absolute 
diff. (ml) 
Relative 
diff. (%) 
1 0.5–1.5 2 3–2 5 
2 1–2 3 2.5–1.5 4 
3 0.5–1.5 2 3–2 5 
4 0–1 1 2.5–1.5 4 
5 0–1 1 3–2 5 
6 -0.5–0.5 0 1–2 3 
7 -0.5–0.5 0 1–2 3 
8 -0.5–0.5 0 0.5–1.5 2 
9 -1–0 -1 0–1 1 
10 -1.5– (-0.5) -2 0–1 1 
11 -1–0 -1 0–1 1 
12 -1.5– (-0.5) -2 -0.5–0.5 0 
13 -1.5– (-0.5) -2 -1–0 -1 
14 -2– (-1) -3 -1–0 -1 
Aver. -0.0714 -0.1429 1.1429 2.2857 
Gam a®  IS -103 In fus ion  Sets Measurement  
Table 4 shows the measurement results with a flow of 
300 ml/h and 50 ml/h controlled by an infusion pump. 
Again, the estimated measurement error ±0.5 ml is 
given. The decreasing trend of the values is visible from 
the data. 
Table 4: The measured flow values for 300 ml/h and 
50 ml/h for Set 5–6. 
Time 
(h) 
Set 5 
- 
300 ml/h 
Set 6 
- 
50 ml/h 
Flow (ml/h) Flow (ml/h) 
1 288 ± 0.5 47 ± 0.5 
2 288 ± 0.5 47.5 ± 0.5 
3 285 ± 0.5 47.5 ± 0.5 
4 282 ± 0.5 47.5 ± 0.5 
5 282 ± 0.5 47 ± 0.5 
6 279 ± 0.5 46.5 ± 0.5 
7 279 ± 0.5 46 ± 0.5 
8 279 ± 0.5 46 ± 0.5 
9 270 ± 0.5 46.5 ± 0.5 
10 270 ± 0.5 46 ± 0.5 
11 270 ± 0.5 46 ± 0.5 
12 270 ± 0.5 45.5 ± 0.5 
13 267 ± 0.5 45 ± 0.5 
14 267 ± 0.5 45 ± 0.5 
The values from Table 4 are plotted in the following 
graphs. Figure 3 shows the measured flow value for 
300 ml/h, and Figure 4 shows the other measured flow 
value. 
The analysis of the values and graphs showed that the 
use of the Gama® IS-103 gravity sets is not adequate. 
The combination of a volumetric pressure pump and 
gravity sets causes the declared flow accuracy to not be 
achieved. None of the measured sets ensures an inaccu- 
 
 
 
 
racy of flow up to ±3%. Again, there is a decreasing 
inflow trend as in the case of the Intrafix® Primeline 
sets. 
 
Fig. 3: The measured flow values compared to reference 
300 ml/h. 
 
Fig. 4: The measured flow values compared to reference 
50 ml/h. 
The following table 5 shows the absolute differential 
and relative differential of the flow values. Values are 
given in a range that includes a possible measurement 
error. These values confirm that the use of gravity sets 
together with the infusion pump causes a low flow that 
does not meet the declared value.  
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Table 5: Absolute and relative difference values for 
Set 5 (300 ml/h) and Set 6 (50 ml/h). 
Time 
(h) 
 
Set 4 
- 
300 ml/h 
Set 5 
- 
50 ml/h 
Absolute 
Difference 
(ml) 
Relative 
Difference 
(%) 
Absolute 
Difference 
(ml) 
Relative 
Difference 
(%) 
1 -11.5– (-12.5) -4 -2.5– (-3.5) -6 
2 -11.5– (-12.5) -4 -2– (-3) -5 
3 -14.5– (-15.5) -5 -2– (-3) -5 
4 -17.5– (-18.5) -6 -2– (-3) -5 
5 -17.5– (-18.5) -6 -2.5– (-3.5) -6 
6 -20.5– (-21.5) -7 -3– (-4) -7 
7 -20.5– (-21.5) -7 -3.5– (-4.5) -8 
8 -29.5– (-30.5) -7 -3.5– (-4.5) -8 
9 -29.5– (-30.5) -10 -3– (-4) -7 
10 -29.5– (-30.5) -10 -3.5– (-4.5) -8 
11 -29.5– (-30.5) -10 -3.5– (-4.5) -8 
12 -29.5– (-30.5) -10 -4– (-5) -9 
13 -32.5– (33.5) -11 -4.5– (-5.5) -10 
14 -32.5– (33.5) -11 -4.5– (-5.5) -10 
Aver. -23.143 -7.7143 -3.6429 -7.2857 
Mechanical  elongation test  
Mechanical tensile strength tests are used to assess 
changes in material properties of the infusion set. These 
were performed at the Department of Applied 
Mechanics, Faculty of Mechanical Engineering, 
VSB-TUO. This laboratory is equipped with the modern 
Testometric M500-50CT (England) shredder. 
A sample of the test material is firmly held between 
the jaws of the machine and stressed by stretching at 
a constant speed until the material ruptures. The course 
of the test is controlled by specialized software and 
recorded by the curve of the force applied to the 
elongation of the test sample. 
In addition to this curve, the resulting test report 
includes accurate records of maximum force, stress, 
absolute elongation and tensile modulus. This quantity 
characterizes the strength of the material and its elastic 
deformation ability, as specified in Hook’s law for 
elastic deformation [16, 17]. For resilient polymeric 
materials, Hook’s law is limited to a small portion of the 
recorded curve. For this reason, for example, Young’s 
modulus is often not given for flexible PVC, but the 
material is characterized by a strength limit which is 
more significant due to the shape of the tensile curve. In 
this case, it is the stress exerted by the maximum force 
𝐹 (𝑁). The specific value of this limit for typical infusion 
set materials varies from source but is approximately in 
the range of 7–25 MPa [1].
Mechanica l  E longat ion Test  Parameter s  
The parameters of the tested sample (length, cross-
section) and jaw movement speed, which was set to 
50 mm/min for tests in this work, are entered in the 
machine. Sample control software parameters the device 
uses to calculate characteristic parameters include 
absolute elongation, strength, strength limit and 
modulus of elasticity. For the tubing to be tested, the 
original cross-section is determined as the content of the 
annulus enclosed by the outer (𝑟2) and inner (𝑟1) 
diameter of the tubing. The used tubing has a cross-
section of 5.498 mm2. The stressed part was tested. The 
length of the test part of the infusion sets was always the 
same and was 10 cm. Unused sets have also been tested 
to compare the properties of used and unused sets. 
Evaluat ion of  Mechanical  E longat ion Test  
The results of each tensile test are produced in the 
form of a protocol by a tear machine. The processing of 
the tensile strength test results of the infusion sets used 
is carried out in such a way as to make judgments about 
the different material properties of each type of set used, 
in particular whether these properties have been affected 
by the blades of the volumetric pump. 
The values of absolute elongation, tensile strength, 
ultimate strength and modulus of elasticity determined 
by mechanical tests performed for the test sets are shown 
in Table 6. The mechanical test results for new, unused 
infusion sets are shown. Comparing the properties of the 
used set and the new set can serve to give a concrete idea 
of whether the use of the set affects its strength. 
Table 6: Overview of mean values of absolute 
elongation, tensile strength, strength limit and modulus 
of elasticity of tests according to the type of sets. Results 
of tests of unused sets. 
 
Absolute 
Elongat. 
(mm) 
Strength 
(N) 
Strength 
limit 
(MPa) 
Modulus 
of 
elasticity 
(MPa) 
Intrafix® 
Primeline 
136.7 67.45 12.27 799.75 
Gama®  
IS-103 
210.6 96.48 17.55 1295.98 
Unused 
Intrafix 
123.9 59.6 10.84 1291.43 
Unused 
Gama 
216.1 102.4 18.63 1018.59 
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It is clear from the results that the monitored flow is 
not significantly influenced by the set flow rate and not 
affected by use. There are differences between the types 
of infusion sets. As a result, the Gama® IS-103 gravity 
sets have an 80 mm longer elongation than the Intrafix® 
Primeline universal sets. The elongation values are 
plotted in Figure 5. 
 
Fig. 5: The measured flow values compared to reference 
50 ml/h. 
Discussion 
Evaluat ion of  f low m easurement  
The accuracy limit is the declared infusion accuracy 
in units of relative deviation. For Forlong 600II, the 
tolerance is ±3%. 
From the above graphs, we can observe a decreasing 
tendency of the course of almost all measurements. The 
reason for reducing the flow is the compression of the 
tubing by the lamellar pumps to a smaller diameter and 
due to the less elasticity of the material, the tubing does 
not have the ability to return to its original state. 
The best results were achieved with the Intra-fix® 
Primeline set, which was able to achieve correct results 
with a rate of ±3% over the 14 hours of the test. It was 
a measurement with a flow rate of 50 ml/h. However, in 
the other cycles, irrespective of the flow rate, it also 
showed values within the tolerances. 
The Gama® IS-103 gravity sets have significantly 
lower values than universal sets. In no case was the 
measured value above the set flow limit, moreover, all 
performed measurement cycles did not reach their 
declared 3% limit by their average states. The average 
relative difference in flow was -6.57%. This is 
consistent with the assumption that the gravity set 
materials are harder than the pressure sets and exhibit 
less elasticity and compliance with peristaltic move-
ments when operating the pump fins, resulting in a low 
flow rate at the start of the infusion cycle and a further 
continuous decrease. 
The results of the measurements indicate that the type 
of the selected set has a greater impact on measurement 
accuracy. The different flow did not show much in the 
measured values. Intrafix® sets had greater accuracy 
and flow with a 50 ml/h setting with an average relative 
difference of flow 0.79%, while an average value 
of -1.97% at a flow rate of 300 ml/h. For the Gama® 
kits, in terms of the set flow rate, better results were 
achieved at a rate of 300 ml/h. 
Evaluat ion of  tens i le  st rength  tests  
An important comparison of possible changes in the 
mechanical properties of infusion set materials due to 
stresses in the infusion pump is the relationship between 
the values of the used kits and the new unused pieces. 
Strength and absolute elongation indicators show that 
even 14-hour use does not have to affect these material 
characteristics. However, the state when comparing the 
elastic moduli is surprising. While the new Intrafix set 
has a more than 50% increase over the average value of 
the pieces used, the elasticity modulus of the new 
Gamma set has dropped by almost 300 MPa. From the 
behaviour of the set, it can be concluded that the Intrafix 
universal set loses its elasticity by use, while the 
material of the Gama gravity kits needs more force to 
achieve the same elongation value after its use. 
Inf luence of  set  destruct ion  on qual ity o f  
treatm ent  
From all these findings, it can be concluded that the 
choice for pressure-based infusion therapy of the correct 
administration kit has a major influence on the dosing 
accuracy. From the safety point of view, the risk that 
swapping the type of infusion set can bring depends on 
many factors. The age, gender or physical fitness of the 
patient, or the nature of the active ingredient adminis-
tered, its amount and concentration may play a role. It 
should be stressed, however, that the inaccuracies that 
have been achieved in the tests in this work are certainly 
not negligible for an intravenous treatment and that the 
staff or operator responsible for the infusion application 
should be cautious and avoid risk factors that could lead 
to misuse. 
Conclusion 
This work aimed to explain the influence of infusion 
set replacement on flow accuracy. The object of testing 
was universal infusion sets and gravity sets of two 
manufacturers to verify the destructive behaviour of 
these sets and the effect of destruction on the accuracy 
of flow using an infusion pump. The question was to 
verify the claim that the replacement of infusion 
 
30 
 
Lekar a technika – Clinician and Technology 2020, vol. 50(1), pp. 23–31, DOI: 10.14311/CTJ.2020.1.04 
ISSN 0301-5491 (Print), ISSN 2336-5552 (Online) 
ORIGINAL RESEARCH 
pressure sets with gravity sets results in a worsening of 
therapy and to substantiate this claim with specific data 
obtained by experimental measurement. Destructive 
effects that may affect the quality of treatment can be 
manifested both by changing the set and the duration of 
treatment, for this reason it was measured in the work 
with infusion sets for 14 hours. 
The obtained data showed that the infusion pump has 
a much smaller destructive effect on the universal sets, 
whose use for dosing is within the tolerated limits. On 
the other hand, measurements with gravity sets showed 
greater inaccuracies beyond the declared dosage value, 
which is likely to indicate that the gravity set materials 
are less resistant to the action of the pump. The material 
properties of the used sets were further verified by 
mechanical tensile strength tests, which showed 
a marked difference between the materials of the univer-
sal and gravity sets and their different reactions to the 
action of the pump fins. Although 14-hour usage did not 
significantly affect the strength of both materials, their 
elasticity varied with the opposite trend, the decline in 
the universal set and the increase in gravity sets. 
To further verify the conclusions of this work, it 
would be advisable to carry out a further flow measure-
ment with multiple pieces of test kits from one manu-
facturer, thereby refining the results and eliminating any 
measurement errors. 
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